Impact de l’asthme sur le travail : une revue de la littérature
Revue Française d'Allergologie, ISSN: 1877-0320, Vol: 65, Issue: 2, Page: 104195
2025
- 1Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures1
- Readers1
Review Description
L’asthme est une maladie très fréquente qui touche des personnes jeunes en âge de travailler et représente ainsi l’une des premières maladies altérant l’activité professionnelle. L’état de santé des employés souffrant d’asthme est responsable d’une diminution de la productivité au travail, par absentéisme et présentéisme, ce qui se traduit entre autres par des coûts indirects importants. Bien que seulement 10 % des asthmatiques rapportent avoir manqué des jours de travail au cours de leur vie à cause de l’asthme, la majorité évoque un présentéisme (présence au travail alors qu’une absence serait justifiée par l’état de santé). La sévérité et surtout le contrôle de l’asthme sont les déterminants majeurs de l’impact de l’asthme sur le travail. L’amélioration du contrôle de l’asthme par un traitement bien conduit améliore la productivité au travail et diminue les coûts de santé liés à l’asthme. Dans l’asthme sévère, les biothérapies semblent réduire l’absentéisme mais peu de données existent sur le présentéisme. Asthma is a very common disease affecting young people in the age of working and therefore represents one of the leading diseases impacting occupational activity. Health condition of employees suffering from asthma is responsible for work productivity loss, through absenteeism and presenteeism, resulting among other things in significant indirect costs. Although only 10% of workers with asthma report asthma-related missing days of work throughout their live, mostly evoke a presenteeism (work attendance whereas work absence would be justified by health status). Severity and even more asthma control are the major determinants of asthma impact on work productivity. Improving asthma control through proper treatment leads to improved work productivity and reduced asthma-related costs. In severe asthma, biologics seem to reduce absenteeism but there is limited data about their effect on presenteeism.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1877032024004160; http://dx.doi.org/10.1016/j.reval.2024.104195; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85210054556&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S1877032024004160; https://dx.doi.org/10.1016/j.reval.2024.104195
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know